Ekso Bionics announces $3.7 million registered direct offering
Evidence notes
- Ekso Bionics entered into a definitive agreement with institutional investors for a registered direct offering expected to raise approximately $3.7 million in gross proceeds.
- The offering was priced at-the-market under Nasdaq rules and consisted of 769,490 shares of common stock at $4.81 per share.
- The raise functioned as financing support for ongoing operations and commercialization rather than a strategic partnership or product event.
Company context
Ekso Bionics develops wearable robotic exoskeletons for rehabilitation, mobility assistance and industrial use cases. Its systems use powered assistance to support human movement rather than replacing the worker or patient with a standalone robot.